Mr. Anil Inani

Anil Inani is the Chief Financial Officer (CFO) of Sterling Biotech Limited (SBL), where he leads the company’s Finance and Strategic Planning functions, driving financial excellence and long-term growth across its biopharmaceutical and gelatin businesses. He is a qualified Chartered Accountant with over 25 years of diverse experience in finance, commercial operations, and strategic leadership.

A seasoned finance professional, Anil brings deep expertise in IPO preparedness, US GAAP & IFRS reporting, treasury and forex management, taxation, ERP implementation, M&A advisory, and digital transformation. His leadership style combines strong financial discipline with business acumen to support agile and sustainable decision-making.

Before joining Sterling Biotech Limited, Anil served as Chief Financial Officer and Head of Commercial Operations at Shiva Pharmachem, where he led finance and strategy across India, Europe, and the USA. He has also held senior leadership roles with global multinationals including DuPont, Isagro Asia, Silox, Avaya Global, ABB, and Italcementi-Zuari. As Whole-Time Director and Board Member at Isagro Asia, he played a pivotal role in post-acquisition integration and driving profitability.

With a consistent track record of enhancing financial performance and enabling strategic growth, Anil Inani brings to SBL a sharp focus on value creation, governance, and operational excellence.